丁桂散联合特拉唑嗪片治疗ⅢB型前列腺炎34例

34 Cases of Ⅲ B-Type Prostatitis Treated with Ding Gui Powder Combined with Terazosin Tablets

目的:观察丁桂散联合特拉唑嗪片治疗ⅢB型前列腺炎的临床疗效。方法:选取ⅢB型前列腺炎气滞血瘀证患者72例,随机分为治疗组和对照组各36例。疗过程中脱落4例:治疗组失访1例,剔除1例(因合并用药被剔除),对照组失访2例;符合方案分析集(PP)68例,治疗组和对照组各34例。对照组给予盐酸特拉唑嗪片治疗,治疗组在对照组治疗的基础上给予丁桂散外敷神阙穴治疗。观察两组患者治疗后中医证侯积分、NIH-CPSI评分、最大尿流率的变化情况。结果:治疗组有效率88.24%,对照组有效率79.41%,两组比较差异无统计学意义(P>0.05);治疗组中医证候积分、NIH-CPSI评分均优于对照组(P<0.05)。结论:丁桂散联合特拉唑嗪片治疗ⅢB型前列腺炎气滞血瘀证疗效显著,可有效缓解患者的临床症状,减少中医证候积分及NIH-CPSI评分,提高患者的生活质量,且未见明显不良反应。

Objective： To observe the clinical curative effect of Ding Gui Powder（ DGP） combined with terazosin tablets in treating III B-type prostatitis. Methods： 72 patients with III B-type prostatitis due to syndrome of qi stagnation and blood stasis were randomly divided into the treatment group and the control group,with 36 cases in each group. During the treatment,4 cases were released： In the treatment group,1 case was not followed up and 1 case was got rid of due to combined use of medicine; In the control group,2 cases were not followed up; So 68 cases met the needs of PP,with 34 in each group. The patients in the control group were given terazosin tablets,while the ones in the treatment group were added DGP for external application on Shenque（ CV8）.Then TCM syndrome integration,NIH-CPSI assessment score,and the changes of the largest urinary flow rate in both groups were observed after the treatment. Results： The total effective rate of the treatment group was 88. 24%,and that of the control group was79. 41%,and the difference between them had no statistical meaning（ P〈0. 05）. The TCM syndrome integration and NIH-CPSI assessment score of the treatment group were all better than those of the control group（ P〈0. 05）. Conclusion： DGP combined with terazosin tablets has good curative effect in treating III B-type prostatitis,can relieve patients＇ clinical symptom,reduce TCM syndrome integration and NIH-CPSI assessment score,improve their life quality,and have no obvious adverse reactions.